Hedge Fund and Insider Trading News: Soleus Capital, Voss Capital, Starboard Value, ZX Squared Capital, Man Group, Ryan Specialty Holdings Inc (RYAN), Charles Schwab Corporation (SCHW), and More
At least one fund is in the black, and several others moved closer to breakeven in October. A number of biopharma hedge funds enjoyed a healthier October.
United States Andre Rzym Biopharma Funds Regain Some Health Institutional Investor Credit Suisse Hedge Fund Coin Voss Capital
Source: insidermonkey.com